Matt Davidson Insider Profile
4 Followers
Matt Davidson, Chief Development Officer, Director at Adial Pharmaceuticals, holds 299.41K shares in Adial Pharmaceuticals (Ticker: ADIL), holds 2.56M shares in Verrica Pharmaceuticals (Ticker: VRCA).
Matt Davidson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matt Davidson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Matt Davidson
Matt Davidson's Trading History
Adial Pharmaceuticals
Jun 16, 2026
Chief Development Officer, Director
Uninformative Buy
―
$1.79M
Verrica Pharmaceuticals
Sep 09, 2019
Ten Percent Owner
Uninformative Sell
210.33K
$12.65M
List of latest transactions for each holding click on a transaction to see Matt Davidson's performance on stock
You May Also Like
Matt Davidson insider profile FAQ
What is the percentage of profitable transactions made by Matt Davidson?
The percentage of profitable transactions made by Matt Davidson is ―.
What is the average return per transaction made by Matt Davidson?
The average return per transaction made by Matt Davidson is ―.
What stocks does Matt Davidson hold?
Matt Davidson holds: ADIL, VRCA stocks.
What was Matt Davidson’s latest transaction?
Matt Davidson latest transaction was an Uninformative Buy of ―.
What was Matt Davidson's most profitable transaction?
Matt Davidson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Matt Davidson's role in Adial Pharmaceuticals?
Matt Davidson's role in Adial Pharmaceuticals is Chief Development Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.